"The Lower Threshold" phenomenon in tumor cells toward endogenous digitalis-like compounds: Responsible for tumorigenesis?
Open Access
- 1 January 2012
- journal article
- review article
- Published by Sakun Publishing House in Journal of Carcinogenesis
- Vol. 11 (1) , 2
Abstract
Since their first discovery as potential anti-cancer drugs decades ago, there is increasing evidence that digitalis-like compounds (DLC) have anti-tumor effects. Less is known about endogenous DLC (EDLC) metabolism and regulation. As stress hormones synthesized in and secreted from the adrenal gland, they likely take part in the hypothalamo-pituitary-adrenal (HPA) axis. In a previous study, we revealed reduced EDLC concentrations in plasma and organs from immune-compromised animals and proposed that a similar situation of a deregulated HPA axis with "adrenal EDLF exhaustion" may contribute to tumorigenesis in chronic stress situations. Here, we put forward the hypothesis that a lowered EDLC response threshold of tumor cells as compared with normal cells increases the risk of tumorigenesis, especially in those individuals with reduced EDLC plasma concentrations after chronic stress exposure. We will evaluate this hypothesis by (a) summarizing the effects of different DLC concentrations on tumor as compared with normal cells and (b) reviewing some essential differences in the Na/K-ATPase of tumor as compared with normal cells (isoform pattern, pump activity, mutations of other signalosome receptors). We will conclude that (1) tumor cells, indeed, seem to have their individual "physiologic" EDLC response range that already starts at pmolar levels and (2) that individuals with markedly reduced (pmolar) EDLC plasma levels are predisposed to cancer because these EDLC concentrations will predominantly stimulate the proliferation of tumor cells. Finally, we will summarize preliminary results from our department supporting this hypothesis.Keywords
This publication has 98 references indexed in Scilit:
- The α1 subunit of the sodium pump could represent a novel target to combat non‐small cell lung cancersThe Journal of Pathology, 2007
- β-Subunit of cardiac Na+-K+-ATPase dictates the concentration of the functional enzyme in caveolaeAmerican Journal of Physiology-Cell Physiology, 2006
- Cardenolide-Induced Lysosomal Membrane Permeabilization Demonstrates Therapeutic Benefits in Experimental Human Non-Small Cell Lung CancersNeoplasia, 2006
- Sodium/potasium ATPase (Na+, K+-ATPase) and ouabain/related cardiac glycosides: a new paradigm for development of anti- breast cancer drugs?Breast Cancer Research and Treatment, 2005
- Ouabain-Like Compound Changes Rapidly on Physical Exercise in Humans and DogsHypertension, 2005
- Digitoxin is a potential anticancer agent for several types of cancerMedical Hypotheses, 1999
- Differential Regulation of Na/K-ATPaseα-subunit Isoform Gene Expressions in Cardiac Myocytes by Ouabain and Other Hypertrophic StimuliJournal of Molecular and Cellular Cardiology, 1997
- Angiotensin II Stimulates Secretion of Endogenous Ouabain From Bovine Adrenocortical Cells via Angiotensin Type 2 ReceptorsHypertension, 1997
- Tissue distribution of an endogenous ligand to the NA,K ATPase moleculeBiochemical and Biophysical Research Communications, 1988
- Oncogenic transformation of chick-embryo fibroblasts by Rous sarcoma virus alters rubidium uptake and ouabain bindingExperimental Cell Research, 1977